Can Psychedelic Therapy Go Mainstream?

In this episode of Up First's Sunday Story, NPR's Rachel Carlson explores the evolving landscape of psychedelic research and its potential to revolutionize mental health treatment. The discussion covers the limitations of current treatments for conditions like depression and PTSD, and how psychedelics, by increasing neuroplasticity in the brain, offer a new approach. Despite obstacles such as federal illegality, there's growing interest in psychedelic therapies, including efforts to engineer drugs that remove the "trip" and studies to improve research methodologies. The episode also examines the increasing accessibility of ketamine for mental health treatment, including at-home services, while also addressing the safety concerns and the importance of holistic care beyond just the drug itself.